GlassScriptPhysician profile
Gorgi Kozeski
NPI 1689817272
$134,153.68
in general payments reported to CMS, 2019-2025
31 companies · $16K in 2025
The $16K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $8,787 · 2021: $16K · 2022: $8,620 · 2023: $6,393 · 2024: $20K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $13K · Travel and Lodging: $3,572 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,386.00 |
| Food and Beverage | $13,225.27 |
| Travel and Lodging | $3,572.37 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $67,564.40 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $26,044.01 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $10,072.10 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Pfizer INC. | $9,895.61 | 2019-2025 | |
| Abbott Laboratories | $5,610.94 | 2021-2025 | Aveir, Agilis Hispro, Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,612.67 | 2022-2025 | Lifevest |
| Medtronic, INC. | $2,930.36 | 2021-2024 | Selectsite, Reveal Linq, Linq II |
| Biosense Webster, INC. | $2,229.78 | 2020-2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $1,963.51 | 2019-2025 | |
| Biotronik INC. | $1,606.85 | 2019-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Medtronic Vascular, INC. | $640.76 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $215.32 | 2021-2023 | Farxiga |
| Bridgebio Pharma, INC. | $105.93 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $94.56 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $82.04 | 2024 | Arcalyst |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $65.52 | 2024 | Impella |
| Inari Medical, INC. | $58.57 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $51.93 | 2022-2023 | |
| Cardiofocus, INC. | $49.07 | 2019 | |
| Angiodynamics, INC. | $45.80 | 2020 | |
| Celonova Biosciences, INC. | $37.31 | 2021 | |
| Atricure, INC. | $25.46 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.86 | 2025 | Keveyis |
| Kestra Medical Technology Services, INC. | $18.04 | 2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $17.55 | 2024 | |
| Glaxosmithkline, LLC. | $16.90 | 2025 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $16.23 | 2022 | |
| Cordis US Corp. | $15.66 | 2025 | Mynx Control Venous |
| Inspire Medical Systems, INC. | $15.22 | 2024 | Inspire |
| Cardiva Medical, INC. | $14.90 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Irhythm Technologies, INC. | $13.82 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gorgi Kozeski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.